Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 USD | -0.33% | -1.29% | -4.97% |
Apr. 30 | B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
Apr. 29 | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
Evolution of the average Target Price on Ovid Therapeutics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Ovid Therapeutics Inc.
B. Riley | |
HC Wainwright | |
BTIG | |
Oppenheimer | |
JonesTrading Institutional Services | |
Citigroup | |
Cantor Fitzgerald |
EPS Revisions
- Stock Market
- Equities
- OVID Stock
- Consensus Ovid Therapeutics Inc.